Skip to main content
Fig. 3 | Future Journal of Pharmaceutical Sciences

Fig. 3

From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential

Fig. 3Fig. 3

a FTIR spectrum of HSPC liposomes (P11); b FTIR spectrum of pH-sensitive formulation (P5); c FTIR spectrum of Brilliant Blue G-250 (BBG-250); d Particle size of formulation (P5) 118 nm; e Zeta potential of formulation (P5) − 25 mV; f Microscopic image of formulation (P5); g TEM image of formulation (P5); h In vitro drug release of formulation pH-sensitive (P5) and HSPC liposomes (P11) in phosphate buffer (pH 6.4); i Graph between % viability and concentration of formulation pH-sensitive (P5) and HSPC liposomes (P11), free dye, Docetaxel (DTX)

Back to article page